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1.
Introduction
Proinsulin is the precursor molecule to insulin, the biologically active agent that decreases blood glucose levels. Hyperproinsulinemia is a very common observation in patients with type 2 diabetes (T2DM) [1] and it has been postulated for over 20 years that an increased ratio of proinsulin to insulin in the blood could be a predictive marker of T2DM [2] . Use of fasting proinsulin concentration as a predictor of glucose intolerance was investigated by Wareham et al [3] who showed an association between elevated fasting proinsulin concentration and transitional progression to diabetes in a 4.5 year longitudinal study.
Recently Pfützner et al [4] reported elevated levels of intact proinsulin indicated a progressive β-cell dysfunction and could be predictive of T2DM progression, these findings add to previous work by this author [5] [6] [7] . Other previous studies have confirmed this association along with progression of cardiovascular disease [8] . Measurement of proinsulin for early detection of beta-cell dysfunction, before deterioration of glycaemic control could allow introduction of lifestyle changes and/or pharmaceutical intervention at an early stage.
Proinsulin may potentially offer advantages over the measurement of insulin. Proinsulin is not as affected as insulin by hepatic metabolism, and furthermore proinsulin assays are now far more specific with little or no cross-reactivity with endogenous or exogenous insulin. As a consequence proinsulin concentrations may have the potential to be used to identify impaired beta cell function prior to the onset of glucose intolerance. In order to use proinsulin measurement in routine clinical practice, the stability of proinsulin needs to be established. Recent work has established the stability of proinsulin stability over a 24 hour period [9] however, the in this study the aim was to investigate the stability of both total and intact proinsulin in whole blood over a period of 3 days when stored at ambient temperature. 
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Materials
Total proinsulin was measured using a total proinsulin ELISA kit (IV2-003, Invitron Ltd, Monmouth, UK). The cross-reactivities in this assay were: intact proinsulin 100%; insulin 2.2%; C-peptide 0%; 32-33 split proinsulin 97%; des 31-32 proinsulin 100%. Intra-assay CVs at 3.0, 51, and 257 pmol/L were 9.9%, 6.3% and 2.4%, respectively. Intact proinsulin was measured using an intact proinsulin luminescence assay kit (IV2-002, Invitron Ltd, Monmouth, UK), which has stated cross-reactivity of: intact proinsulin 100%; insulin 0%; Cpeptide 0%, 32-33 split proinsulin 5.6%; des 31-32 proinsulin 1.4%. Intra-assay CVs at 3.5
and 54 pmol/L were 4.9% and 5.3%, respectively. Both proinsulin assays were calibrated against the WHO 1 st International Standard for proinsulin (IRP 84/611). Results were processed on MikroWin curve fitting software (Mikrotek Laborsysteme GmbH, Germany).
Glucose was determined using a glucose oxidase method (YSI 2300, Yellow Springs Instruments, UK).
Methods
Following an overnight fast, all subjects underwent a 75g OGTT. 4ml of blood was drawn from all subjects into K2EDTA blood tubes (Becton Dickinson, Oxford, UK) at 0, 60 and 120 minutes during an OGTT. Samples were transported immediately to the lab as whole blood and the samples inverted and mixed thoroughly before a 1ml aliquot was taken from each. 
3.
Results
A range of total and intact proinsulin concentrations were achieved by taking both fasting and post-glucose load samples (total proinsulin range 3-882 pmol/L; intact proinsulin range 2-187 pmol/L).
3.1.
Stability of total proinsulin
Stability of total proinsulin in whole blood over 72 hours is shown in Figure 1 
Stability of intact proinsulin
Stability data for intact proinsulin in whole blood over 72 hours is displayed in Figure 2 .
There Figure   2B ). Mean bias at 72 hours was 6.2% ( Figure 2C ). 4.
Discussion
Elevated circulating proinsulin levels can result from a stressed pancreas releasing insulin precursors, in an attempt to counteract insulin resistance and increased blood glucose concentrations. Measurement of proinsulin may therefore be of use as a measure of β-cell dysfunction for screening individuals who, without intervention, could progress to glucose intolerance. However, for this to be possible particularly within a primary care setting, proinsulin would need to be sufficiently stable in whole blood to account for the transfer time to the local laboratory. Our study was designed to mimic the transportation setting that such samples would be exposed to; alongside this, the study also followed the recommended validation and stability protocols of blood collection tubes [10, 11] . A recent study found no degradation over a 24 hour period, however, transportation time in routine use may exceed this [9] . We observed stability based on the 72 hour values as a percentage of baseline concentration for total proinsulin of 123% (95% CI 119-127%) and 107% (95% CI 105-109%) for intact proinsulin. This related to a small increase in a mean difference of 20.3pmol/L for total proinsulin and a negligible change of 1.6pmol/L for intact proinsulin which would not be considered clinically significant. The larger change in total proinsulin over 72 hours was not due to assay variation, but may be explained by changes in proinsulin split products after several days of standing, which have different cross-reactivities in the total proinsulin assay. Variations in cross-reactivities for the different split products in alternative total proinsulin assays should therefore be a consideration.
5.
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Conclusion
In conclusion proinsulin, especially intact proinsulin, is very stable in whole blood. When collected into EDTA tubes and left unseparated at ambient room temperature for at least 72 hours, there was little degradation; this enables transport and handling from a primary care setting to a laboratory testing facility, enabling its potential use as a biomarker for diagnosis of glucose intolerance. Due to showing better agreement with baseline levels after 72 hours, intact proinsulin may be the more appropriate choice.
